Stay updated on Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    On 2025-10-29, the record was updated to include a Results Posted entry, adding the Results, Outcome Measures, and Study Status details. The 2025-07-08 entry for 'Results Submitted' was removed, and the 2025-10-15 version 36 consolidates these updates.
    Difference
    0.5%
    Check dated 2025-11-03T21:25:13.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    10%
    Check dated 2025-10-06T06:36:41.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.2%
    Check dated 2025-09-29T03:15:13.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    New substantial study-status and outcome-measures content added, including sections for participant flow, baseline characteristics, results, adverse events, quality control, and a return date.
    Difference
    3%
    Check dated 2025-09-22T00:13:21.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.6%
    Check dated 2025-09-14T21:30:03.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.6%
    Check dated 2025-09-07T17:29:49.000Z thumbnail image

Stay in the know with updates to Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.